A randomized controlled clinical trial of combination therapy for type 2 diabetes by vildagliptin, metformin, and α-glucosidase inhibitor
… In summary, vildagliptin in combination with metformin and α-glucosidase inhibitors can reduce FBG, PPG, and HbA1c of type 2 diabetes without the risk of gaining weight and may …..... Read More